Phase 2b Study of ALTO-100 in MDD

Summary

The purpose of this study is to determine efficacy differences between ALTO-100 and placebo, used either as monotherapy or adjunctively to an antidepressant, related to patient characteristics.

Timeline

Start

2023-01-10

Primary completion

2024-09-05

Completion

2024-10-24

Drugs

Indications